399 related articles for article (PubMed ID: 12642598)
1. The pore region of the skeletal muscle ryanodine receptor is a primary locus for excitation-contraction uncoupling in central core disease.
Avila G; O'Connell KM; Dirksen RT
J Gen Physiol; 2003 Apr; 121(4):277-86. PubMed ID: 12642598
[TBL] [Abstract][Full Text] [Related]
2. Distinct effects on Ca2+ handling caused by malignant hyperthermia and central core disease mutations in RyR1.
Dirksen RT; Avila G
Biophys J; 2004 Nov; 87(5):3193-204. PubMed ID: 15347586
[TBL] [Abstract][Full Text] [Related]
3. Functional effects of central core disease mutations in the cytoplasmic region of the skeletal muscle ryanodine receptor.
Avila G; Dirksen RT
J Gen Physiol; 2001 Sep; 118(3):277-90. PubMed ID: 11524458
[TBL] [Abstract][Full Text] [Related]
4. Calcitonin gene-related peptide restores disrupted excitation-contraction coupling in myotubes expressing central core disease mutations in RyR1.
Vega AV; Ramos-Mondragón R; Calderón-Rivera A; Zarain-Herzberg A; Avila G
J Physiol; 2011 Oct; 589(Pt 19):4649-69. PubMed ID: 21825032
[TBL] [Abstract][Full Text] [Related]
5. Central core disease mutations R4892W, I4897T and G4898E in the ryanodine receptor isoform 1 reduce the Ca2+ sensitivity and amplitude of Ca2+-dependent Ca2+ release.
Du GG; Khanna VK; Guo X; MacLennan DH
Biochem J; 2004 Sep; 382(Pt 2):557-64. PubMed ID: 15175001
[TBL] [Abstract][Full Text] [Related]
6. Excitation--contraction uncoupling by a human central core disease mutation in the ryanodine receptor.
Avila G; O'Brien JJ; Dirksen RT
Proc Natl Acad Sci U S A; 2001 Mar; 98(7):4215-20. PubMed ID: 11274444
[TBL] [Abstract][Full Text] [Related]
7. Two central core disease (CCD) deletions in the C-terminal region of RYR1 alter muscle excitation-contraction (EC) coupling by distinct mechanisms.
Lyfenko AD; Ducreux S; Wang Y; Xu L; Zorzato F; Ferreiro A; Meissner G; Treves S; Dirksen RT
Hum Mutat; 2007 Jan; 28(1):61-8. PubMed ID: 16958053
[TBL] [Abstract][Full Text] [Related]
8. Ca2+ release in muscle fibers expressing R4892W and G4896V type 1 ryanodine receptor disease mutants.
Lefebvre R; Legrand C; Groom L; Dirksen RT; Jacquemond V
PLoS One; 2013; 8(1):e54042. PubMed ID: 23308296
[TBL] [Abstract][Full Text] [Related]
9. Reduced threshold for store overload-induced Ca
Chen W; Koop A; Liu Y; Guo W; Wei J; Wang R; MacLennan DH; Dirksen RT; Chen SRW
Biochem J; 2017 Aug; 474(16):2749-2761. PubMed ID: 28687594
[TBL] [Abstract][Full Text] [Related]
10. Altered ryanodine receptor function in central core disease: leaky or uncoupled Ca(2+) release channels?
Dirksen RT; Avila G
Trends Cardiovasc Med; 2002 Jul; 12(5):189-97. PubMed ID: 12161072
[TBL] [Abstract][Full Text] [Related]
11. FKBP12 binding to RyR1 modulates excitation-contraction coupling in mouse skeletal myotubes.
Avila G; Lee EH; Perez CF; Allen PD; Dirksen RT
J Biol Chem; 2003 Jun; 278(25):22600-8. PubMed ID: 12704193
[TBL] [Abstract][Full Text] [Related]
12. Ca2+-dependent excitation-contraction coupling triggered by the heterologous cardiac/brain DHPR beta2a-subunit in skeletal myotubes.
Sheridan DC; Carbonneau L; Ahern CA; Nataraj P; Coronado R
Biophys J; 2003 Dec; 85(6):3739-57. PubMed ID: 14645065
[TBL] [Abstract][Full Text] [Related]
13. Triadin binding to the C-terminal luminal loop of the ryanodine receptor is important for skeletal muscle excitation contraction coupling.
Goonasekera SA; Beard NA; Groom L; Kimura T; Lyfenko AD; Rosenfeld A; Marty I; Dulhunty AF; Dirksen RT
J Gen Physiol; 2007 Oct; 130(4):365-78. PubMed ID: 17846166
[TBL] [Abstract][Full Text] [Related]
14. Divergent Activity Profiles of Type 1 Ryanodine Receptor Channels Carrying Malignant Hyperthermia and Central Core Disease Mutations in the Amino-Terminal Region.
Murayama T; Kurebayashi N; Yamazawa T; Oyamada H; Suzuki J; Kanemaru K; Oguchi K; Iino M; Sakurai T
PLoS One; 2015; 10(6):e0130606. PubMed ID: 26115329
[TBL] [Abstract][Full Text] [Related]
15. Defects in Ca2+ release associated with local expression of pathological ryanodine receptors in mouse muscle fibres.
Lefebvre R; Legrand C; González-Rodríguez E; Groom L; Dirksen RT; Jacquemond V
J Physiol; 2011 Nov; 589(Pt 22):5361-82. PubMed ID: 21969454
[TBL] [Abstract][Full Text] [Related]
16. Single channel properties of heterotetrameric mutant RyR1 ion channels linked to core myopathies.
Xu L; Wang Y; Yamaguchi N; Pasek DA; Meissner G
J Biol Chem; 2008 Mar; 283(10):6321-9. PubMed ID: 18171678
[TBL] [Abstract][Full Text] [Related]
17. Ryanodine receptor mutations in malignant hyperthermia and central core disease.
McCarthy TV; Quane KA; Lynch PJ
Hum Mutat; 2000; 15(5):410-7. PubMed ID: 10790202
[TBL] [Abstract][Full Text] [Related]
18. Functional defects in six ryanodine receptor isoform-1 (RyR1) mutations associated with malignant hyperthermia and their impact on skeletal excitation-contraction coupling.
Yang T; Ta TA; Pessah IN; Allen PD
J Biol Chem; 2003 Jul; 278(28):25722-30. PubMed ID: 12732639
[TBL] [Abstract][Full Text] [Related]
19. Ryanodine modification of RyR1 retrogradely affects L-type Ca(2+) channel gating in skeletal muscle.
Bannister RA; Beam KG
J Muscle Res Cell Motil; 2009; 30(5-6):217-23. PubMed ID: 19802526
[TBL] [Abstract][Full Text] [Related]
20. Calmodulin binding to the 3614-3643 region of RyR1 is not essential for excitation-contraction coupling in skeletal myotubes.
O'Connell KM; Yamaguchi N; Meissner G; Dirksen RT
J Gen Physiol; 2002 Sep; 120(3):337-47. PubMed ID: 12198090
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
